RPS BioPharma Holdings, LP
RPS BioPharma Holdings, LP is a private investment fund based in George Town, Cayman Islands. According to its most recent Form D, filed Apr 10, 2017, it has sold $149,581,598 of interests to 21 investors since its first sale in Mar 2017. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Pharma Management (Cayman) Ltd; Rory Riggs; Pablo Legorreta.
- Total raised
- $149,581,598Cumulative sales reported on Form D
- Investors
- 21
- First sale
- Mar 27, 2017
- Minimum investment
- $100,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Pharma Management (Cayman) Ltd; Rory Riggs; Pablo Legorreta
- Latest Form D
- Apr 10, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about RPS BioPharma Holdings, LP
What is the minimum investment for RPS BioPharma Holdings, LP?
According to its latest Form D, filed Apr 10, 2017, the minimum investment RPS BioPharma Holdings, LP accepts from an outside investor is $100,000.
Who can invest in RPS BioPharma Holdings, LP?
RPS BioPharma Holdings, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has RPS BioPharma Holdings, LP raised?
RPS BioPharma Holdings, LP reports $149,581,598 sold from 21 investors on its Form D filed Apr 10, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is RPS BioPharma Holdings, LP based?
RPS BioPharma Holdings, LP is based in George Town, Cayman Islands.
When did RPS BioPharma Holdings, LP launch?
RPS BioPharma Holdings, LP reports its first sale in Mar 2017.
Size compared with every private investment fund
Raised more than 75% of the 576 private investment funds based in Cayman Islands, and more than 76% of all 10,363 that report sales.